imipramine has been researched along with moclobemide in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (9.09) | 18.7374 |
1990's | 23 (41.82) | 18.2507 |
2000's | 12 (21.82) | 29.6817 |
2010's | 14 (25.45) | 24.3611 |
2020's | 1 (1.82) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Bhosale, SH; Shelke, SM | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Sen, S; Sinha, N | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Alam, MM; Alex, AT; Bansal, S; Chaudhary, A; Jaiswal, V; Joseph, A; Suthar, SK; Tiwari, A | 1 |
Guelfi, JD; Roth, M | 1 |
Andreeva, NI; Golovina, SM; Mashkovskiĭ, MD; Rumiantsev, EA | 1 |
Andreeva, NI; Golovina, SM; Mashkovskiĭ, MD; Parshin, VA | 1 |
Baumhackl, U; Gallhofer, B; Geretsegger, C; Hebenstreit, GF; Loidl, M; Radmayr, E; Saletu, M; Schöny, W; Stabl, M | 1 |
Figueira, IL; Nardi, AE; Stabl, M; Versiani, M | 1 |
Márquez, CA; Portes, N; Traballi, CA; Ucha Udabe, R | 1 |
Guelfi, JD; Lecrubier, Y | 1 |
Casacchia, M; Moll, E | 1 |
Alves, A; Mundim, FD; Nardi, AE; Schmid-Burgk, W; Versiani, M | 1 |
Berger, M; Bizière, K | 1 |
Casacchia, M; Rossi, A | 1 |
Alterwain, P; Capponi, R; Dajas, F; Heinze-Martin, G; Marquez, CA; Oggero, U; Poleo, MA; Rivero-Almanzor, LE; Rossel, L; Versiani, M | 1 |
Baumhackl, U; Bizière, K; Fischbach, R; Geretsegger, C; Hebenstreit, G; Radmayr, E; Stabl, M | 1 |
Alves, AB; Mundim, FD; Nardi, AE; Versiani, M | 1 |
Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
Kok, LP; Tsoi, WF | 1 |
Pétursson, H | 1 |
Boerner, RJ | 1 |
Brodribb, TR; Downey, M; Gilbar, PJ | 1 |
Delle Chiaie, R; Donnini, M; Gambino, C; Pancheri, P; Seripa, S; Trillo, L; Vicario, E | 1 |
Angst, J; Scheidegger, P; Stabl, M | 1 |
Jääskeläinen, J; Kaartinen, P; Kalli, A; Kilponen, E; Koskinen, T; Nikkilä, H; Pirttiperä, V; Rimón, R; Seppälä, J | 1 |
Angst, J; Delini-Stula, A; Mikkelsen, H | 1 |
Amrein, R; Stabl, M; Versiani, M | 1 |
Barros, HM; Ferigolo, M; Marquardt, AR; Tannhauser, M | 1 |
Meyers, BS | 1 |
Versiani, M | 1 |
Bekaroğlu, M; Bilici, M; Değer, O; Karahan, SC; Orem, A; Soylu, C | 1 |
Silverstone, T | 1 |
Chojnacka-Wójcik, E; Kłodzińska, A; Stachowicz, K; Tatarczyńska, E | 1 |
Barros, HM; Gomez, R; Kopittke, L | 1 |
Chojnacka-Wójcik, E; Nikiforuk, A; Tatarczyńska, E; Wesołowska, A | 1 |
Fava, M; Papakostas, GI | 1 |
Nikiforuk, A; Wesołowska, A | 1 |
Bogo, MR; Bonan, CD; Cognato, Gde P; Henz, SL; Sarkis, JJ; Vuaden, FC | 1 |
Fisar, Z; Hroudová, J; Raboch, J | 1 |
Aswar, UM; Bhosale, SH; Bodhankar, SL; Kalshetti, PP; Shelke, SM | 1 |
Gacar, N; Gocmez, SS; Utkan, T | 1 |
Niedzielska, E; Nowak, G; Pałucha-Poniewiera, A; Pilc, A; Pomierny, B; Pomierny-Chamioło, L; Siwek, A | 1 |
Baldwin, DS; Green, M; Montgomery, SA | 1 |
Poleszak, E; Serefko, A; Wlaź, P; Wróbel, A | 1 |
Cao, L; Chen, J; Li, G; Li, J; Lin, D; Pan, J; Pang, C; Ruan, L; Xie, X; Xu, Y; Yan, Q; Yu, X; Zhang, C; Zhang, N | 1 |
Bryk, A; Bryniarski, P; Filipczak-Bryniarska, I; Kozlowski, M; Kuszmiersz, P; Myszka, M; Nazimek, K; Nowakowski, J; Strobel, S; Tyszka, A | 1 |
Huang, YH; Yeh, CT | 1 |
5 review(s) available for imipramine and moclobemide
Article | Year |
---|---|
Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating Scale.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Diagnosis-Related Groups; Humans; Imipramine; Moclobemide; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic | 1993 |
Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzamides; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Maprotiline; Mianserin; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Personality Assessment; Psychomotor Agitation; Treatment Outcome | 1995 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Drug Administration Schedule; Dysthymic Disorder; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors; Placebos; Selective Serotonin Reuptake Inhibitors | 1998 |
A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Topics: Depressive Disorder, Major; Disorders of Excessive Somnolence; Fatigue; Headache; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders | 2006 |
19 trial(s) available for imipramine and moclobemide
Article | Year |
---|---|
The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Depressive Disorder; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors | 1992 |
Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Austria; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Prospective Studies; Psychiatric Status Rating Scales | 1990 |
Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Blood Pressure; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors | 1990 |
Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzamides; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales | 1990 |
Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Humans; Imipramine; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales | 1990 |
Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Single-Blind Method | 1990 |
Moclobemide, imipramine and placebo in the treatment of major depression.
Topics: Ambulatory Care; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors; Prospective Studies; Psychiatric Status Rating Scales | 1990 |
Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Retrospective Studies | 1990 |
A comparison of moclobemide and imipramine in treatment of depression.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Psychiatric Status Rating Scales; Random Allocation | 1989 |
A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Benzamides; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic | 1989 |
Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
Topics: Adjustment Disorders; Adult; Aged; Aged, 80 and over; Austria; Benzamides; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Prospective Studies; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic | 1989 |
Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
Topics: Adult; Benzamides; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Time Factors | 1989 |
A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Prospective Studies; Treatment Outcome | 1995 |
Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.
Topics: Aged; Antidepressive Agents; Anxiety; Benzamides; Cognition; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Memory; Moclobemide; Psychiatric Status Rating Scales; Wechsler Scales | 1994 |
A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Prospective Studies | 1994 |
Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.
Topics: Adult; Aged; Ambulatory Care; Benzamides; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospitalization; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Personality Inventory | 1993 |
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Constipation; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Tremor; Xerostomia | 1997 |
Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Severity of Illness Index; Treatment Outcome | 2001 |
Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
Topics: Adolescent; Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Moclobemide; Recurrence; Young Adult | 2014 |
31 other study(ies) available for imipramine and moclobemide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis, antidepressant evaluation and QSAR studies of novel 2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)-N-(substituted phenyl)acetamides.
Topics: Acetamides; Animals; Antidepressive Agents; Linear Models; Mice; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents.
Topics: Animals; Antidepressive Agents; Benzylidene Compounds; Clorgyline; Imipramine; Indoles; Lactams; Mice; Moclobemide; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2015 |
[Anticalcium activity of several antidepressive agents].
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Benzamides; Brain; Calcium; Calcium Chloride; Carbazoles; Female; Imipramine; Male; Mice; Moclobemide; Oxazines; Rats; Verapamil | 1992 |
[Effects of antidepressive agents on tolerance of hypoxia and physical exercise].
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Carbazoles; Carbolines; Female; Hypoxia; Imipramine; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Oxazines; Physical Exertion; Piracetam; Rats; Swimming | 1991 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia.
Topics: Benzamides; Depressive Disorder; Fluoxetine; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors; Placebos; Treatment Outcome | 1995 |
[Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy].
Topics: Adult; Agoraphobia; Antidepressive Agents; Behavior Therapy; Benzamides; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Imipramine; Male; Moclobemide; Panic Disorder | 1995 |
Efficacy and adverse effects of moclobemide.
Topics: Adult; Benzamides; Drug Interactions; Female; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome | 1994 |
Comparison of behavioral effects of moclobemide and deprenyl during forced swimming.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Benzamides; Imipramine; Male; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Phenethylamines; Psychotropic Drugs; Rats; Rats, Wistar; Selegiline; Swimming | 1998 |
Effects of antidepressant treatments on polymorphonuclear elastase levels in patients with depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Biomarkers; Depressive Disorder, Major; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Imipramine; Leukocyte Count; Leukocyte Elastase; Male; Moclobemide; Neutrophils; Treatment Outcome | 2000 |
Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Depression; Desipramine; Imipramine; Male; Moclobemide; Monoamine Oxidase Inhibitors; Oxadiazoles; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Swimming | 2004 |
Opposite effects of antidepressants on unstimulated and stimulated salivary flow.
Topics: Amylases; Animals; Antidepressive Agents; Calcium; Fluoxetine; Imipramine; Male; Moclobemide; Muscarinic Agonists; Phosphates; Pilocarpine; Rats; Rats, Wistar; Saliva; Salivary Proteins and Peptides; Salivation; Xerostomia | 2005 |
Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Citalopram; Desipramine; Drug Interactions; Imipramine; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Phenols; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulfonamides; Swimming | 2007 |
The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Drug Synergism; Imipramine; Injections, Intraperitoneal; Male; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulfonamides | 2008 |
Influence of antidepressant drugs on Ecto-nucleotide pyrophosphatase/phosphodiesterases (E-NPPs) from salivary glands of rats.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cells, Cultured; Fluoxetine; Hydrolysis; Imipramine; Male; Moclobemide; Phosphoric Diester Hydrolases; Phosphorylation; Pyrophosphatases; Rats; Rats, Wistar; Salivary Proteins and Peptides; Submandibular Gland; Thymidine Monophosphate; Time Factors | 2009 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.
Topics: Acetamides; Acetanilides; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoxetine; Imipramine; Male; Moclobemide; Olfaction Disorders; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Triazines | 2012 |
Chronic administration of imipramine but not agomelatine and moclobemide affects the nitrergic relaxation of rabbit corpus cavernosum smooth muscle.
Topics: Acetamides; Acetylcholine; Animals; Dose-Response Relationship, Drug; Imipramine; Male; Moclobemide; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Nitroprusside; Penis; Rabbits; Time Factors | 2013 |
Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors.
Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Cerebral Cortex; Citalopram; Excitatory Amino Acid Antagonists; Hippocampus; Imipramine; Male; Moclobemide; Morpholines; Pyridines; Radioligand Assay; Rats, Wistar; Reboxetine; Receptor, Metabotropic Glutamate 5; Thiazoles; Tritium | 2014 |
The depressogenic-like effect of acute and chronic treatment with dexamethasone and its influence on the activity of antidepressant drugs in the forced swim test in adult mice.
Topics: Amitriptyline; Animals; Antidepressive Agents; Citalopram; Depression; Dexamethasone; Dose-Response Relationship, Drug; Glucocorticoids; Imipramine; Male; Mianserin; Mice; Moclobemide; Motor Activity; Neuropsychological Tests; Swimming; Thiazepines | 2014 |
Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems.
Topics: Animals; Antidepressive Agents; Corpus Striatum; Coumaric Acids; Disease Models, Animal; Drug Evaluation, Preclinical; Frontal Lobe; Hippocampus; Hypothalamus; Imipramine; Immobilization; Male; Mice; Mice, Inbred ICR; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Physical Exertion; Serotonin; Stress, Physiological; Stress, Psychological; Swimming | 2015 |
Repeatedly administered antidepressant drugs modulate humoral and cellular immune response in mice through action on macrophages.
Topics: Animals; Antidepressive Agents; Biomarkers; Cytokines; Depressive Disorder; Dermatitis, Contact; Fluoxetine; Imipramine; Immunity, Cellular; Immunity, Humoral; Immunosuppression Therapy; Injections, Intraperitoneal; Macrophages; Male; Mice; Mice, Inbred Strains; Moclobemide; Venlafaxine Hydrochloride | 2016 |
Anticancer Effects of Antidepressants in Hepatocellular Carcinoma Cells.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Carcinoma, Hepatocellular; Humans; Imipramine; Liver Neoplasms; Mianserin; Moclobemide; Selective Serotonin Reuptake Inhibitors | 2023 |